Cancer-Associated Thrombosis on Bevacizumab: Risk of Recurrence and Bleeding When Bevacizumab Is Stopped or Continued

Mayenga, M; Falvo, N; Mahé, I; Jannot, AS; Gazeau, B; Meyer, G; Gendron, N; Sanchez, O; Djennaoui, S; Planquette, B

Mayenga, M (通讯作者)，Hop Europeen Georges Pompidou, AP HP, Dept Pulmonol & Intens Care, F-75015 Paris, France.

CANCERS, 2023; 15 (15):

Abstract

Simple Summary Cancer-associated thrombosis is a frequent complication and a poor prognostic event. Bevacizumab is an antiangiogenic drug used in the ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索